Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher K Rayner

Showing results (81-90 of 251) with videos related to

Pageof 26
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 2, 2011
The alpha (α)-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adultsDiana Gentilcore, Lora Vanis, Judith M Wishart, et al.
Diabetes, Obesity & Metabolism|January 8, 2019
Metformin attenuates the postprandial fall in blood pressure in type 2 diabetesMalcolm J Borg, Karen L Jones, Zilin Sun, et al.
The American Journal of Medicine|September 2, 2006
Artificially sweetened versus regular mixers increase gastric emptying and alcohol absorptionKeng-Liang Wu, Reawika Chaikomin, Selena Doran, et al.
Diabetes, Obesity & Metabolism|June 25, 2021
Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesMichael Horowitz, Christopher K Rayner, Chinmay S Marathe, et al.
Acta Diabetologica|November 17, 2014
Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in healthChinmay S Marathe, Michelle Bound, Kylie Lange, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of MetforminMalcolm J Borg, Christopher K Rayner, Karen L Jones, et al.
Nutrients|August 27, 2021
Potential for Gut Peptide-Based Therapy in Postprandial HypotensionMalcolm J Borg, Cong Xie, Christopher K Rayner, et al.
Diabetes Research and Clinical Practice|August 31, 2014
Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?Tongzhi Wu, Sony S Thazhath, Michelle J Bound, et al.
Peptides|August 13, 2017
Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy malesTongzhi Wu, Christopher K Rayner, Linda E Watson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjectsLaurence G Trahair, Michael Horowitz, Trygve Hausken, et al.
Pageof 26

Showing results (81-90 of 251) with videos related to

Sort By:
Pageof 26
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 2, 2011
The alpha (α)-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adultsDiana Gentilcore, Lora Vanis, Judith M Wishart, et al.
Diabetes, Obesity & Metabolism|January 8, 2019
Metformin attenuates the postprandial fall in blood pressure in type 2 diabetesMalcolm J Borg, Karen L Jones, Zilin Sun, et al.
The American Journal of Medicine|September 2, 2006
Artificially sweetened versus regular mixers increase gastric emptying and alcohol absorptionKeng-Liang Wu, Reawika Chaikomin, Selena Doran, et al.
Diabetes, Obesity & Metabolism|June 25, 2021
Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesMichael Horowitz, Christopher K Rayner, Chinmay S Marathe, et al.
Acta Diabetologica|November 17, 2014
Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in healthChinmay S Marathe, Michelle Bound, Kylie Lange, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of MetforminMalcolm J Borg, Christopher K Rayner, Karen L Jones, et al.
Nutrients|August 27, 2021
Potential for Gut Peptide-Based Therapy in Postprandial HypotensionMalcolm J Borg, Cong Xie, Christopher K Rayner, et al.
Diabetes Research and Clinical Practice|August 31, 2014
Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?Tongzhi Wu, Sony S Thazhath, Michelle J Bound, et al.
Peptides|August 13, 2017
Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy malesTongzhi Wu, Christopher K Rayner, Linda E Watson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjectsLaurence G Trahair, Michael Horowitz, Trygve Hausken, et al.
Pageof 26